Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mingqi Liu

Showing results (71-80 of 132) with videos related to

Pageof 14
Sort By:
British Journal of Pharmacology|August 4, 2025
Short-chain fatty acids regulate T cell heterogeneity to alleviate recurrent spontaneous abortionYao Yao, Xiaoyu Cai, Dan He, et al.
Theranostics|March 14, 2025
Unveiling the potential of biomechanics in pioneering innovative strategies for cancer therapyXiaodong Wu, Weidong Fei, Tao Shen, et al.
Microorganisms|March 29, 2023
Characterization of Two Novel Rumen-Derived Exo-Polygalacturonases: Catalysis and Molecular SimulationsQian Deng, Xiaobao Sun, Deying Gao, et al.
Acta Biomaterialia|August 2, 2021
Sialic acid conjugate-modified liposomes enable tumor homing of epirubicin via neutrophil/monocyte infiltration for tumor therapyJunqiang Ding, Dezhi Sui, Mingqi Liu, et al.
Journal of Dairy Science|January 8, 2025
Comparing the antioxidant effects of single and binary combinations of Lactiplantibacillus plantarum in vitro and in vivo and their application in yogurtKun Yang, Bingjing Zhou, Qianping Xu, et al.
Frontiers in Neuroscience|March 26, 2024
Cognitive impairment in Chinese traumatic brain injury patients: from challenge to future perspectivesTao Liu, Shaohui Yu, Mingqi Liu, et al.
Burns & Trauma|September 27, 2024
The pharmacological landscape of chronic subdural hematoma: a systematic review and network meta-analysis of randomized and non-randomized controlled studiesTao Liu, Zhihao Zhao, Mingqi Liu, et al.
Drug Delivery|May 28, 2026
Lysosome-directed targeted protein degradation technologies for overcoming cancer drug resistance: mechanisms, design principles, and therapeutic opportunitiesHuixin Mao, Ying Zhang, Mingqi Liu, et al.
International Journal of Pharmaceutics|December 5, 2024
Combating tumor PARP inhibitor resistance: Combination treatments, nanotechnology, and other potential strategiesRong Wang, Yunxi Liu, Mingqi Liu, et al.
Brain Communications|September 4, 2024
Cerebral microbleeds in patients with COVID-19: is there an inevitable connection?Yuchang Wang, Yuetao Hu, Ruichen Zhao, et al.
Pageof 14

Showing results (71-80 of 132) with videos related to

Sort By:
Pageof 14
British Journal of Pharmacology|August 4, 2025
Short-chain fatty acids regulate T cell heterogeneity to alleviate recurrent spontaneous abortionYao Yao, Xiaoyu Cai, Dan He, et al.
Theranostics|March 14, 2025
Unveiling the potential of biomechanics in pioneering innovative strategies for cancer therapyXiaodong Wu, Weidong Fei, Tao Shen, et al.
Microorganisms|March 29, 2023
Characterization of Two Novel Rumen-Derived Exo-Polygalacturonases: Catalysis and Molecular SimulationsQian Deng, Xiaobao Sun, Deying Gao, et al.
Acta Biomaterialia|August 2, 2021
Sialic acid conjugate-modified liposomes enable tumor homing of epirubicin via neutrophil/monocyte infiltration for tumor therapyJunqiang Ding, Dezhi Sui, Mingqi Liu, et al.
Journal of Dairy Science|January 8, 2025
Comparing the antioxidant effects of single and binary combinations of Lactiplantibacillus plantarum in vitro and in vivo and their application in yogurtKun Yang, Bingjing Zhou, Qianping Xu, et al.
Frontiers in Neuroscience|March 26, 2024
Cognitive impairment in Chinese traumatic brain injury patients: from challenge to future perspectivesTao Liu, Shaohui Yu, Mingqi Liu, et al.
Burns & Trauma|September 27, 2024
The pharmacological landscape of chronic subdural hematoma: a systematic review and network meta-analysis of randomized and non-randomized controlled studiesTao Liu, Zhihao Zhao, Mingqi Liu, et al.
Drug Delivery|May 28, 2026
Lysosome-directed targeted protein degradation technologies for overcoming cancer drug resistance: mechanisms, design principles, and therapeutic opportunitiesHuixin Mao, Ying Zhang, Mingqi Liu, et al.
International Journal of Pharmaceutics|December 5, 2024
Combating tumor PARP inhibitor resistance: Combination treatments, nanotechnology, and other potential strategiesRong Wang, Yunxi Liu, Mingqi Liu, et al.
Brain Communications|September 4, 2024
Cerebral microbleeds in patients with COVID-19: is there an inevitable connection?Yuchang Wang, Yuetao Hu, Ruichen Zhao, et al.
Pageof 14